B.I.T. - BREAST IN TRANSLATION 2.0

• MARIA VITTORIA DIECI· DIRIGENTE MEDICO
• CLAUDIO VERNIERI· DIRIGENTE MEDICO

• PHILIPPE AFTIMOS· RELATORE
• FRANCO BERRINO· MODERATORE
• CARMEN CRISCITIELLO· RELATORE
• CARMINE DE ANGELIS· RELATORE
• MARCO DEMARIA· RELATORE
• MARIA VITTORIA DIECI· MODERATORE
• MATTIA GARUTTI· RELATORE
• LORENZO GERRATANA· RELATORE
• FABIO GIRARDI· RELATORE
• GAIA GRIGUOLO· TUTOR
• VALENTINA GUARNERI· RELATORE
• LUCA MAGNANI· RELATORE
• LUCA MALORNI· TUTOR
• QING-JUN MENG· RELATORE
• FEDERICA MIGLIETTA· TUTOR
• MAFALDA OLIVEIRA· RELATORE
• TITO PANCIERA· RELATORE
• STEFANO PICCOLO· RELATORE
• BARBARA PISTILLI· RELATORE
• ANTONIO ROSATO· MODERATORE
• ANGELA TOSS· RELATORE
• CLAUDIO VERNIERI· RELATORE

Ragione sociale

DELPHI INTERNATIONAL SRL

Stato accreditamento

STANDARD - 1° rinnovo

Di processo

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide. Progresses achieved in pharmacologic therapies and treatment personalization is progressively raising breast cancer cure rates and prolonging survival in patients with advanced disease. Taking basic science advancements into everyday clinical practice remains a major issue, and it is achieved through translational research, which comes with incredible opportunities but also increasing challenges at an academic level. In the current scenario of innovative therapeutic approaches, novel diagnostic and molecular tools, and the evolution of personalized oncology algorithms, contamination between scientific and clinical disciplines is key to fuel the translational process.

#3Documentazione clinica. Percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza - profili di cura

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

100

Verifica presenza

Sistema Elettronico A Badges

Verifica apprendimento

Questionario A Risposta Multipla Online